ClinicalTrials.gg
RecruitingNCT06777498PNNYUpdated Jul 11, 2025

The Precision Nutrition New York Study

An interventional study of Whole Grain Intervention then fruits and vegetables and Fruit and Vegetable Intervention and then whole grains in Body Composition Changes and Body Weight Changes, sponsored by Cornell University. Recruiting at 1 site in United States. Open to participants aged 21 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-11.

Sponsored by Cornell University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Started Jan 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
21 Years to 50 Years
Sex
All
01

Study summary

Dietary fiber has been shown to have beneficial effects on human health through its impact on microbes present in the gut. However, these effects can vary between individuals, and everyone may not reap the same health benefits by eating the same sources of fiber. Factors predicting how an individual's gut microbes as well as the beneficial metabolites produced by these microbes change in response to different sources of fiber would be helpful in developing precision nutrition approaches that maximize the benefits of dietary fiber. The objective of this study is to evaluate candidate predictors of gut microbiota response to fiber sources from either whole grains or fruits and vegetables.

02

Conditions studied

  • Body Composition Changes
  • Body Weight Changes

Browse trials for

Keywords

  • dietary fiber
  • gut microbiome
  • gut microbiota
  • short-chain fatty acids
  • SCFAs
  • whole grains
  • fruits
  • vegetables
03

In context

Body Weight Changes

231 studies on the registry are indexed under Body Weight Changes; 30 are open to participants now.

This study's planned enrollment of 15 is below the median of 80 across 179 interventional studies indexed under Body Weight Changes.

Browse Body Weight Changes studies →

Lead sponsor

Cornell University is the lead sponsor of 103 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age is between 21-50 years
  • is between 25-30. You can check your BMI here: https://www.cdc.gov/bmi/adult-calculator/index.html
  • Must be able to have height, weight, waist, and hip circumference, and body composition measured during the study
  • Must be able to provide saliva samples.
  • Must be able to provide a phone number and email address at which the study investigators can contact for study-related matters.
  • Must be able to increase dietary fiber intake to the recommended level following the instructions on the USDA MyPlate website: https://www.myplate.gov/myplate-plan
  • Must be able to provide food records of everything consumed (food, beverage, and supplements) on one weekday and one weekend day (example Tuesday, Saturday) every week during the study. This will be done using an online survey.
  • Must be able to provide 10 stool samples over 11 weeks of the study duration. 18) Must have stable weight (within ±3% of usual body weight) for the last two months.
  • Must be able to to take an online survey to assess recent dietary fiber intake to determine eligibility.

Exclusion criteria

Exclusion Criteria:

  • Electronic medical implant, for example, a pacemaker.
  • An existing, UNTREATED, thyroid condition.
  • Use of systemic antibiotics (intravenous injection, intramuscular, or oral) within the last 4 months.
  • An acute disease at the time of enrollment (Acute disease is defined as the presence of a moderate or severe illness with or without fever).
  • A chronic, (unresolved, requiring ongoing medical management or medication) pulmonary, cardiovascular, gastrointestinal, hepatic, or renal functional abnormality.
  • Any suspected state of or immunodeficiency including .
  • A history of active UNTREATED gastrointestinal disorders or diseases including

    1. Inflammatory bowel disease (IBD)
    2. Ulcerative colitis (mild-moderate-severe)
    3. Crohn's or celiac disease
    4. Indeterminate colitis
    5. Irritable bowel syndrome (IBS) (moderate-severe)
    6. Persistent, infectious gastroenteritis, colitis or gastritis
    7. Persistent or chronic diarrhea of unknown etiology
    8. Clostridium difficile infection (recurrent)
    9. Chronic constipation
  • Previously had bariatric surgery.
  • An unstable dietary history as defined by major changes in diet during the previous month. For example, elimination or significantly increased intake of a major food group in the diet.
  • Recent history of chronic alcohol consumption defined as more than 5 drinks (or servings) of alcohol per day.
  • Female participants: pregnant/lactating.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Experimental: Group A: Whole grains then fruits and vegetables

    Whole grain intervention then fruits and vegetables

    Other: Whole Grain Intervention then fruits and vegetables

  • Experimental
    Experimental: Group B: Fruits and vegetables then whole grains

    Fruits and vegetables intervention then whole grains

    Other: Fruit and Vegetable Intervention and then whole grains

Interventions

  • OtherWhole Grain Intervention then fruits and vegetables

    TREATMENT 1: Participants will eat whole grains that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when they eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual. TREATMENT 2: Participants will eat fruits and vegetables that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when participants eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual.

  • OtherFruit and Vegetable Intervention and then whole grains

    TREATMENT 1: Participants will eat fruits and vegetables that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when participants eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual. TREATMENT 2: Participants will eat whole grains that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when they eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual.

06

What researchers measure

Primary outcomes

  1. Body weight changes

    For each intervention (whole grains \& fruits and vegetables), investigators will measure change in body weight in kg = Post-intervention minus Pre-intervention

    Time frame: 3-4 weeks

  2. Body fat percentage changes

    For each intervention (whole grains \& fruits and vegetables), investigators will measure change in fat percentage = Post-intervention minus Pre-intervention

    Time frame: 3-4 weeks

Secondary outcomes

  1. Gut microbiome measured by 16S rRNA gene sequencing

    For each intervention (whole grains \& fruits and vegetables), investigators will calculate changes in relative abundance (proportion) of each gut bacterium from Pre-intervention to Post-intervention.

    Time frame: 3-4 weeks

  2. Fecal short-chain fatty acid concentrations (SCFAs)

    For each intervention (whole grains \& fruits and vegetables), investigators will measure change in SCFA concentrations = Post-intervention minus Pre-intervention. We will report the SCFAs acetate, butyrate, and propionate.

    Time frame: 3-4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — We will NEVER share de-identified data about the participants. Our previous publications show aggregated data results. This study is identical to our previous in design, sample types, and data being collected. We shared the de-identified 16S rRNA sequence data of the participants in a public database as requested by the journals. When requested by a journal, we have shared eligibility criteria. Some journals may require us to share our statistical code.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Oct 2025, 8 months after the start.

Of 90 non-industry interventional studies with no phase under Body Weight Changes, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 8 months is below that.

Counting every sponsor, half of 99 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 6, 2025
First posted
Jan 16, 2025
StartActual
Jan 13, 2025
Primary completionEst.
Oct 1, 2025
CompletionEst.
Dec 31, 2025
Last update
Jul 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06777498
Lead sponsor
Cornell University
Responsible party
Sponsor
First posted
Jan 16, 2025
Start date
Jan 13, 2025
Primary completion
Oct 1, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jul 11, 2025

Study contacts

Angela Poole
Contact
pnnystudy@cornell.edu
607-255-8796
Colette Strathman
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion